Key Takeaways
- ORCL shares declined for nine consecutive trading sessions, losing 24% — marking the longest losing streak since late 2021.
- Shares hover around $140, representing a 27% decline over six months and approaching 52-week lows.
- Wall Street remains overwhelmingly positive, with 84% of analysts maintaining Buy recommendations and a consensus target of $254.84.
- Market jitters focus on Oracle’s escalating capital expenditures and increasing debt levels tied to AI infrastructure.
- Piper Sandler projects approximately $2.2 billion in untapped OCI revenue for fiscal 2027 not reflected in current forecasts.
Oracle (ORCL) shares rebounded in Monday’s pre-market session, climbing approximately 3.5% after enduring nine straight days of declines. The prolonged slide erased 24% of the stock’s value — representing the most severe losing streak since December 2021.
Shares currently trade near $140.27, hovering close to 52-week lows and marking a 27% retreat over the past half-year. For perspective, the stock now sits 57% beneath its record closing peak achieved on September 10, 2025.
The selloff’s timing is particularly notable given the broader technology software sector’s recent resilience. The iShares Expanded Tech-Software Sector ETF recorded five consecutive winning sessions through last Thursday, accumulating gains exceeding 10%. Oracle bucked that trend entirely.
Since reaching a 2026 peak of $248.15 on June 1, shares have declined on 18 of the subsequent 22 trading days. This represents a persistent downturn rather than temporary volatility.
Market Concerns Driving the Decline
The primary issue troubling investors isn’t related to growth prospects. Rather, it’s the mounting expenditure requirements. Market participants are anxious about Oracle’s substantial capital expenditure obligations and expanding debt burden. The company’s aggressive AI infrastructure buildout demands significant financial resources.
Piper Sandler maintained its Overweight rating with a $225 target while acknowledging these investor apprehensions directly. The firm highlighted concerns surrounding capital requirements for AI infrastructure development, customer concentration risks, margin pressures, and uncertainty about how AI investments translate into revenue generation.
Mizuho analyst Siti Panigrahi, among the street’s most optimistic voices with a $320 target, acknowledged Oracle will probably require external financing to support its capital expenditure plans. He identified “financing challenges” as a material risk factor — even while designating the stock as a top pick.
The Bullish Case Remains Intact
Despite the sharp decline, analyst sentiment remains remarkably positive. A full 84% of analysts covering ORCL maintain Buy ratings, according to FactSet data. That percentage has only been exceeded once in two decades — briefly during May 2011.
The consensus price target stands at $254.84 — suggesting approximately 82% upside potential from last Thursday’s closing price.
KeyBanc elevated its estimates last month, expressing growing confidence that operating expense growth will remain disciplined. The firm maintained its Overweight rating with a $300 target, citing cost management as a key driver for future appreciation.
Evercore ISI sustained its Outperform rating with a $245 target, emphasizing Oracle’s substantial AI backlog and noting that current remaining performance obligations reached $77 billion.
Piper Sandler’s research introduces an additional perspective: the firm anticipates roughly 2,400 megawatts of OCI capacity potentially launching in fiscal 2027, which could generate approximately $2.2 billion in revenue not currently incorporated into consensus projections.
Freedom Broker adjusted its target downward to $210 from $230 while maintaining a Buy rating, characterizing Oracle’s transformation toward AI compute infrastructure as a favorable long-term development.
Oracle’s PEG ratio currently registers at 0.69, which Piper Sandler interprets as indicating the stock appears undervalued compared to its growth trajectory.
Trailing twelve-month revenue growth reached 17%, and Piper Sandler suggested the new CFO might introduce more conservative guidance — potentially recalibrating expectations in a manner that provides the stock with recovery momentum.


